Advisory Resource Group Takes $964,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisory Resource Group bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 1,947 shares of the medical equipment provider's stock, valued at approximately $964,000.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Onefund LLC boosted its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after acquiring an additional 18 shares in the last quarter. AlphaCore Capital LLC raised its holdings in Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after purchasing an additional 18 shares during the period. Parkside Financial Bank & Trust boosted its position in Intuitive Surgical by 2.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider's stock worth $390,000 after purchasing an additional 19 shares in the last quarter. Accredited Investors Inc. grew its holdings in Intuitive Surgical by 1.9% in the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after purchasing an additional 19 shares during the period. Finally, Second Line Capital LLC increased its position in shares of Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on ISRG shares. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Piper Sandler cut their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Finally, Truist Financial decreased their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 215 shares of the company's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the transaction, the senior vice president now owns 1,768 shares of the company's stock, valued at $970,738.08. This represents a 10.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 4,998 shares of company stock worth $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Down 0.5%

Shares of ISRG stock opened at $509.49 on Thursday. The company's 50-day moving average price is $527.31 and its 200-day moving average price is $537.92. The stock has a market cap of $182.61 billion, a price-to-earnings ratio of 74.71, a PEG ratio of 5.43 and a beta of 1.67. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the firm earned $1.50 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.